Log in

NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

$26.66
+0.57 (+2.18 %)
(As of 04/3/2020 02:57 AM ET)
Today's Range
$25.68
Now: $26.66
$27.17
50-Day Range
$22.73
MA: $33.26
$46.02
52-Week Range
$22.11
Now: $26.66
$57.85
Volume158,900 shs
Average Volume159,392 shs
Market Capitalization$511.31 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More
Orthofix Medical logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$459.95 million
Cash Flow$2.85 per share
Book Value$17.22 per share

Profitability

Net Income$-28,460,000.00

Miscellaneous

Employees1,055
Market Cap$511.31 million
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.


Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

How has Orthofix Medical's stock been impacted by COVID-19 (Coronavirus)?

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have decreased by 13.1% and is now trading at $26.66. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Orthofix Medical.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Monday, February, 24th. The medical device company reported $0.51 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.51. The medical device company had revenue of $121.49 million for the quarter, compared to analysts' expectations of $122.90 million. Orthofix Medical had a positive return on equity of 8.58% and a negative net margin of 6.19%. View Orthofix Medical's earnings history.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its first quarter 2020 After-Hours earnings guidance on Monday, February, 24th. The company provided earnings per share (EPS) guidance of 0.09-0.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.32. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $113.27 million.

What price target have analysts set for OFIX?

2 brokerages have issued twelve-month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 83.8% from the stock's current price. View analysts' price targets for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

News articles about OFIX stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutOrthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 224,700 shares, a drop of 40.4% from the February 27th total of 377,300 shares. Based on an average daily trading volume, of 174,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 1.2% of the shares of the company are sold short. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $26.66.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $511.31 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe. View additional information about Orthofix Medical.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is http://www.orthofix.com/.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]


MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  371 (Vote Outperform)
Underperform Votes:  438 (Vote Underperform)
Total Votes:  809
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/3/2020 by MarketBeat.com Staff

Featured Article: Cryptocurrencies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel